Le Lézard
Classified in: Health
Subjects: LEG, AVO

Phivida Comments on U.S. Senate Activity on CBD Legislation

VANCOUVER and SAN DIEGO, Sept. 17, 2019 /CNW/ - Phivida Holdings Inc. (CSE: VIDA OTCQX: PHVAF) ("Phivida"), is pleased to see that today, senate majority leader Mitch McConnell has introduced report language that would require the FDA to issue formal "enforcement discretion" on the sale of hemp CBD products.

Phivida Holdings Inc. (CNW Group/Phivida Holdings Inc.)

It is expected that the U.S. Senate Appropriations Subcommittee on Agriculture will "mark up" the language submitted by Senator McConnell, which will require the FDA to:

According to a report from the U.S. Hemp Roundtable, Senator McConnell's announcement will pave the way for CBD products to become formally recognized as a safe and legal substance as a matter of federal law and will expedite the FDA's processes in doing so. The bill will be marked up by the full Senate Appropriations Committee on Thursday and could go to the full Senate soon.

"This is a huge step not only for us but also for the industry at large. This decision marks an important moment for the CBD industry, and can potentially augment Phivida's national reach, and provide greater national clarity to the industry as a whole" stated Jim Bailey, CEO of Phivida Holdings Inc. "While the passing of the Farm Bill allowed industrial hemp and CBD industry to conduct extensive research and develop new products, this federal legislative change has the potential to enable companies like ours to bring our full portfolio of products  to the market with products that consumers are demanding."

For more information on Phivida products, please visit www.feelOki.com and www.hempvidaplus.com 

ABOUT Phivida Holdings Inc.
Phivida Holdings Inc. is headquartered in Vancouver, BC with operations in San Diego, CA. Phivida is a premium functional food and beverage company focused on whole plant nutrition and natural ingredients that help best maintain overall health and balance in the human body. The company infuses organic active hemp extract into a variety of premium beverages and clinical products for everyday health. Phivida embraces and celebrates a return to organic, natural, plant-based foods and beverages, and a focus on holistic health and wellness. The mission is to help reduce the world's dependence on pharmaceuticals and provide food and beverage choices that allow customers to live a balanced, healthy lifestyle. For more information, visit phivida.com.

Related Links


SOURCE Phivida Holdings Inc.

These press releases may also interest you

at 09:50
Zymeworks Inc. , a clinical stage biopharmaceutical company developing multifunctional biotherapeutics ("Zymeworks" or the "Company"), announced today the closing of its previously announced underwritten public offering (the "Offering"). The Offering...

at 09:45
Kerrisdale Capital, a private investment manager, has published a report explaining its short position in Principia Biopharma Inc. , a biopharmaceutical company whose $2 billion valuation is driven by misleading clinical data and an ineffective...

at 09:45
The "Fragile X Syndrome (FXS) - Market Insights, Epidemiology, and Market Forecast - 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth understanding of the disease, historical & forecasted...

at 09:40
The "6-Hour Virtual Seminar on Qualification (IQ, OQ, PQ) and Validation of Laboratory Equipment and Systems for Regulated Industries (Pharma, Biotech, Devices)" webinar has been added to ResearchAndMarkets.com's offering. This webinar will aim at...

at 09:30
Valencell, the leading innovator in wearable biometric sensor technology, today announced it has secured financing from strategic investors led by Halma plc, a FTSE 100 global group of life-saving technology companies, with additional participation...

at 09:15
The "Generalized Anxiety Disorder (GAD) - Market Insights, Epidemiology, and Market Forecast - 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. This report deliver an in-depth understanding of the disease, historical &...

News published on 17 september 2019 at 14:31 and distributed by: